Evaluation of Moringa Oleifera Leaf Extract Versus Sodium Hypochlorite in Pulpectomy of Nonvital Primary Molars

Launched by CAIRO UNIVERSITY · Apr 24, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of Moringa Oleifera leaf extract compared to Sodium Hypochlorite in treating nonvital primary molars in children aged 3 to 7 years. Nonvital primary molars are baby teeth that have become infected or damaged, and the trial aims to see which treatment helps heal the tooth better over a period of 12 months. Researchers will look at signs like pain, swelling, and tooth movement, as well as take X-rays to check if the tooth is healing properly.

To be eligible for the trial, children must be between 3 and 7 years old, able to cooperate during treatment, and have specific dental issues that require a pulpectomy (a procedure to clean out the infected tooth). However, children with certain health problems, teeth that are too damaged, or those who have had previous treatments on the tooth will not be included. If your child qualifies and participates, they will receive one of the two treatments and will be monitored for any changes in their condition over the year.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cooperative children aged between 3-7 years
• • Males/Females.
• • Primary molars necessitating pulpectomy diagnosed with deep dental caries with pulp necrosis and periapical pathosis or both.
• • Systemically healthy children
• Exclusion Criteria:
• • Medically compromised and uncooperative children
• • Tooth indicated for extraction due to root resorption more than two thirds of the root, teeth near exfoliation, deep subgingival caries hindering proper coronal seal.
• • Mobile teeth (Miller's Grade 2 or more)
• • Previous pulp therapy